Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by the onset of seizures between 3 and 20 months of age (peak 6 months). Seizures may be frequent at onset but usually remit within 1 year from the onset. In untreated cases there can be isolated or brief clusters of seizures within the period from onset to remission. A minority of individuals may have epilepsy in later life. Some patients (with PRRT2 mutations) may develop paroxysmal kinesiogenic dyskinesia in later life.
Biomarker and diagnostic research for self-limited familial infantile epilepsy has been reported in the published literature.
No clinical trials have been registered for self-limited familial infantile epilepsy.
69 publications have been identified in PubMed for self-limited familial infantile epilepsy. Kisho has analyzed 51 by research type. Research spans Epidemiology / Natural History (31%), Review / Meta-Analysis (25%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 16 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:36 AM UTC
Research summaries |
13 |
25% |
Clinical study results | 6 | 12% |
Other research | 5 | 10% |
Testing and diagnosis research | 5 | 10% |
Patient case studies | 3 | 6% |
Laboratory research | 2 | 4% |
New treatment approaches | 1 | 2% |
Thoral E (2026). [PMID: 42126105](https://pubmed.ncbi.nlm.nih.gov/42126105/). *J Fish Biol*. [Basic Science / Preclinical]
Boonstra A (2026). [PMID: 41969051](https://pubmed.ncbi.nlm.nih.gov/41969051/). *Psychol Med*. [Clinical Trial Publication]
Nada M (2026). [PMID: 41324630](https://pubmed.ncbi.nlm.nih.gov/41324630/). *Annals of plastic surgery*. [Clinical Trial Publication]
Desjarlais M (2026). [PMID: 42113773](https://pubmed.ncbi.nlm.nih.gov/42113773/). *PLoS One*. [Other]
Nishijo T (2026). [PMID: 41742307](https://pubmed.ncbi.nlm.nih.gov/41742307/). *Acta neuropathologica communications*. [Basic Science / Preclinical]
Fischer L (2025). [PMID: 40057422](https://pubmed.ncbi.nlm.nih.gov/40057422/). *Health policy (Amsterdam, Netherlands)*. [Review / Meta-Analysis]
Myagila K (2025). [PMID: 40927705](https://pubmed.ncbi.nlm.nih.gov/40927705/). *Frontiers in artificial intelligence*. [Gene Therapy / Novel Therapeutics]
M B (2025). [PMID: 40255315](https://pubmed.ncbi.nlm.nih.gov/40255315/). *Bioinformation*. [Diagnostic / Biomarker]
Sekandi JN (2025). [PMID: 39715573](https://pubmed.ncbi.nlm.nih.gov/39715573/). *JMIR mHealth and uHealth*. [Clinical Trial Publication]
Kharashgah M (2025). [PMID: 40346339](https://pubmed.ncbi.nlm.nih.gov/40346339/). *Aesthetic plastic surgery*. [Epidemiology / Natural History]